G protein-gated, inwardly rectifying K ؉ channels (GIRK) are effectors of G protein-coupled receptors for neurotransmitters and hormones and may play an important role in the regulation of neuronal excitability. GIRK channels may be important in neurodevelopment, as suggested by the recent finding that a point mutation in the pore region of GIRK2 (G156S) is responsible for the weaver (wv) phenotype. The GIRK2 G156S gene gives rise to channels that exhibit a loss of K ؉ selectivity and may also exert dominantnegative effects on G ␤␥ -activated K ؉ currents. To investigate the physiological role of GIRK2, we generated mutant mice lacking GIRK2. Unlike wv͞wv mutant mice, GIRK2 ؊͞؊ mice are morphologically indistinguishable from wild-type mice, suggesting that the wv phenotype is likely due to abnormal GIRK2 function. Like wv͞wv mice, GIRK2 ؊͞؊ mice have much reduced GIRK1 expression in the brain. They also develop spontaneous seizures and are more susceptible to pharmacologically induced seizures using a ␥-aminobutyric acid antagonist. Moreover, wv͞؊ mice exhibit much milder cerebellar abnormalities than wv͞wv mice, indicating a dosage effect of the GIRK2 G156S mutation. Our results indicate that the weaver phenotypes arise from a gain-of-function mutation of GIRK2 and that GIRK1 and GIRK2 are important mediators of neuronal excitability in vivo.
G protein-gated, inwardly rectifying K ϩ channels (GIRK) are regulated by neurotransmitters and hormones through G protein-coupled receptors (1) (2) (3) . GIRK channels are believed to determine neuronal membrane excitability by selectively permitting the flux of K ϩ ions near the resting membrane potential (4) (5) (6) (7) . The weaver mouse, a neurological mutant characterized by extensive cerebellar granule cell death during development (8) (9) (10) , age-dependent dopaminergic neuronal loss in the substantia nigra (11, 12) , male infertility (13) , and spontaneous seizures (14) , carries a G156S point mutation in the pore-forming region H5 of GIRK2 (15) . This mutation leads to a loss of K ϩ selectivity of homomeric GIRK2 channels and strongly reduces heteromeric GIRK1͞GIRK2 channel function (16) (17) (18) . Electrophysiological recordings from weaver and wild-type cerebellar granular cells have yielded conflicting reports, supporting either a loss of K ϩ selectivity (16) or a loss of channel function (19) . To study the physiological effects of GIRK2 in vivo and to address the question whether the phenotypic defects in the weaver mouse are due to gain-offunction effects such as the loss of K ϩ selectivity or due to loss-of-function or dominant-negative effects on GIRK1͞ GIRK2 heteromultimeric channels, we have generated GIRK2-deficient mice and compared them to mice carrying one or two copies of the wv allele but no wild-type GIRK2 gene.
MATERIALS AND METHODS

Genomic Cloning and Construction of a Targeting Vector.
Genomic clones containing the murine GIRK2 gene were isolated from a FIX II murine 129͞Sv genomic library (Stratagene) by screening the library using the full-length hamster GIRK2 cDNA as a probe (20) . Two identical phage clones containing the entire murine GIRK2 gene were identified, and three exons containing the entire open reading frame were mapped. To generate the GIRK2 targeting vector pPNT-76, an Ϸ8-kb EcoRI fragment containing exon 1 and part of exon 2 was inserted into the targeting vector pPNT (21) such that its 3Ј end was adjacent to the PGK promotor upstream of the neomycin gene. The 3Ј end of the targeting construct was generated from the same GIRK2 genomic clone and contained a 0.47-kb BglII-XbaI fragment that was inserted into the exon 2 EcoRI͞BglII deletion and included sequences from exon and intron 2 ( Fig. 1 A) . The targeting vector was linearized by NotI and electroporated into R1 embryonic stem (ES) cells at 200 V and 800 mF. Stable colonies were grown under double selection in 350 g͞ml G418 and 0.2 mM gancyclovin in ES cell medium (22) . By Southern blotting, 150 colonies were analyzed for homologous recombination. One clone (G2) was identified by the presence of a 1.9-kb BglII band and was microinjected into blastocysts to generate GIRK2-deficient mice (Fig. 1B) .
Western Blot Analysis. Mouse brain membrane (50 g), prepared as described (23, 24) , was solubilized in 2% SDS͞ sample buffer (125 mM Tris, pH 6.8͞20% glycerol͞5% 2-mercaptoethanol) and loaded onto each lane. Western blots were probed with 1 g͞ml affinity-purified rabbit polyclonal antibodies against the N terminus of GIRK2 or GIRK1 or against the C terminus of IRK1 (23) . Donkey anti-rabbit-horseradish peroxidase was used as secondary antibody at 1:5000 dilution. The blots were developed with enhanced chemiluminescence reagents (Amersham) and exposed to Hyperfilm-ECL (Amersham).
Immunohistochemistry. Mice were perfused intracardially with 4% formaldehyde and 0.1% glutaraldehyde in PBS (pH 7.4). Brains were dissected and postfixed overnight at 4ЊC. Fifty-micrometer vibratome sections were collected in 0.1 M Tris (pH 7.6); blocked with 2% H 2 O 2 ; washed in 50 mM Tris, pH 7.5͞100 mM NaCl͞0.1% Triton X-100 (TBST); and then blocked in 4% normal goat serum and 3% BSA in TBST.
Rabbit antibodies were affinity-purified, and sections were incubated in 1-2 g͞ml primary antibody overnight (23, 24) . Monoclonal antibodies against tyrosine hydroxylase (TH; PelFreez Biologicals) were used at 1:1000. Biotinylated donkey anti-rabbit or anti-mouse IgG Fab (The Jackson Laboratory) were used at 1:200, and sections were developed with the ABC kit (Vector Laboratories) and diaminobenzidine.
Induction of Seizures Using Pentylenetetrazole (PTZ). PTZ (Sigma) was dissolved in PBS and injected i.p. at a dose of 50 mg͞kg in Ϸ0.1 ml. Animals were housed in a room with controlled light͞dark cycle (12 hr light͞12 hr dark) and temperature (23ЊC). All experiments were performed between 11 a.m. and 1 p.m. Animals were injected and observed without prior knowledge of their genotype. Each mouse was placed in a transparent cage and observed for 30 min after injection. All mice were littermates between 10 and 14 weeks of age and weighed Ն20 g.
RESULTS AND DISCUSSION
Generation of GIRK2 Null Mice. The GIRK2 gene was disrupted in ES cells by homologous recombination using a targeting vector in which exon 2 was disrupted and partially deleted by a pgk-neomycin resistance cassette (Fig. 1A) . One ES cell clone that carried the targeted allele was used to generate chimeric male animals that passed the mutant allele to their offspring. GIRK2 ϩ͞Ϫ mice were indistinguishable from wild-type mice and were inbred to produce GIRK2 Ϫ͞Ϫ mice (Fig. 1B) . No normal GIRK2 mRNA could be detected in brains of adult GIRK2 Ϫ͞Ϫ mice by RT-PCR analysis, but a truncated GIRK2 mRNA was present (Fig. 1C) . No GIRK2 immunoreactivity was detectable using antibodies against either the N terminus or C terminus of GIRK2 (Figs. 2A and 3 A and B; data not shown). We conclude, therefore, that we have generated GIRK2 null mice.
Down-Regulation of GIRK1 Protein in GIRK2 Null Mice. GIRK2 Ϫ͞Ϫ mice are born at the expected frequency and are viable. Given that GIRK2 and GIRK1 have partly overlapping temporal and spatial expression patterns and are known to form functional heteromultimers in vitro (16) (17) (18) (25) (26) (27) (28) and in vivo (24) , we examined the expression of GIRK1 and other related inward rectifier channels by using affinity-purified polyclonal antibodies against GIRK1, IRK1, and GIRK4 in Western blot and immunohistochemical studies of GIRK2 ϩ͞ϩ, ϩ͞Ϫ, and Ϫ͞Ϫ mice. Immunoblot analysis showed that GIRK1 levels were reduced in brain membranes of GIRK2 ϩ͞Ϫ mice and nearly undetectable in Ϫ͞Ϫ mice, whereas IRK1 protein levels remained constant in mice of all three genotypes (Fig. 2 A) . RT-PCR analysis showed that GIRK1, GIRK4, and IRK1 mRNA were similar in all animals, suggesting that the down-regulation of GIRK1 in GIRK2 Ϫ͞Ϫ mice occurred posttranscriptionally (Fig. 2B) . Immunohistochemical analysis showed dramatic reduction of GIRK1 immunoreactivity in many brain regions in GIRK2 Ϫ͞Ϫ mice, whereas IRK1 and GIRK4 immunoreactivities were normal in these GIRK2 mutants (Fig. 3 A and B; data not shown). The extent of reduction in GIRK1 varied with the brain regions; expression of GIRK1 in the cerebral cortex and hippocampus was virtually undetectable, whereas in the cerebellum, significant amounts of GIRK1 remained in the granule cell layer (Fig. 3 A and B) . The reduction of GIRK1 protein levels throughout the brain suggests that a majority of GIRK1 proteins in the brain interact with GIRK2, and in the absence of GIRK2, there is a concurrent loss of GIRK1 subunits that normally form heteromultimers with GIRK2.
Differences Between the GIRK2 Null Phenotypes and the Weaver Phenotypes. The GIRK2 Ϫ͞Ϫ and wv͞wv mice showed striking differences. Visual inspection and histological examination of the brain and other organs of GIRK2 Ϫ͞Ϫ animals revealed no anomalies. GIRK2 Ϫ͞Ϫ mice exhibited normal cerebellar morphology except for the reduced GIRK1 and GIRK2 protein expression (Fig. 3 B and D) . Midbrain dopaminergic neurons and their dendrites also appeared normal despite the absence of GIRK2 protein (Fig. 3C) . While male wv͞wv mice are infertile, male GIRK2 Ϫ͞Ϫ mice are fertile; superovulated CD-1 mice mated with either GIRK2 Ϫ͞Ϫ males or their wild-type littermates produced a comparable number of fertilized eggs. The apparent normal phenotype in GIRK2 Ϫ͞Ϫ mice provides strong evidence that loss of homomeric GIRK2 channel and͞or heteromeric GIRK1͞GIRK2 channel function is not the primary cause of the weaver phenotype.
The Weaver Gene Dosage Effect. When GIRK2 Ϫ͞Ϫ mice were compared with mice carrying one or two copies of the wv allele (GIRK2 wv͞Ϫ and͞or wv͞wv), we found that both Ϫ͞Ϫ and wv͞Ϫ mice exhibit normal locomotive behavior, unlike the wv͞wv mice. In ϩ͞ϩ, Ϫ͞Ϫ, and wv͞Ϫ animals, there was no obvious loss of TH-positive neurons or dendrites in the substantia nigra pars compacta or in the ventral tegmental area, whereas substantial cell loss was evident in the substantia nigra pars compacta of the wv͞wv midbrain (Fig. 3C ). In the substantia nigra pars compacta and ventral tegmental area of wv͞Ϫ mice, GIRK2 immunoreactivity was present but of lower intensity. In contrast to the heterozygous GIRK2 ϩ͞Ϫ mice, most of the GIRK2 immunoreactivity in the wv͞Ϫ mice was found in the cell bodies of the dopaminergic neurons; the GIRK2 immunoreactivity in the dendrites was much reduced (Fig. 3C) . The size and gross morphology of the cerebellum of wv͞Ϫ animals are not significantly different from that of the wild-type animals. Histologically, the wv͞Ϫ cerebellum appeared more similar to that of the wv͞ϩ (8, 9) than the cerebellum of ϩ͞ϩ or wv͞wv mice. The wv͞Ϫ granule cell layer often appeared thinner. The Purkinje cell layer was disorganized in various locations, and some of the Purkinje cells were found deep in the granule cell layer (Fig. 3D) . The similarity between wv͞Ϫ and wv͞ϩ cerebella and the difference between wv͞Ϫ and wv͞wv cerebella suggest that cerebellar development is sensitive to the dosage of the GIRK2 G156S mutant gene.
Seizure Activities of GIRK2 Null Mice. The GIRK2 Ϫ͞Ϫ mice exhibited sporadic seizures characterized by jerking of head and body, vocalization, and infrequently progression to a tonic-clonic seizure. Typically, the episodes lasted for 30 sec and were followed by complete physical inactivity. All witnessed seizures occurred when some kind of stress was exerted on the animal (changing cages, setting up matings), and the behavior of mice returned to normal after the seizure. Seizures were never observed before weaning and seemed to occur at equal frequencies in young and old mutant mice. Pharmacological challenge with the convulsant agent PTZ (29), a ␥-aminobutyric acid antagonist, revealed that GIRK2 Ϫ͞Ϫ mice were hyperexcitable when challenged with a single injection of PTZ (50 mg͞kg). At this dose, 70% of GIRK2 Ϫ͞Ϫ mice but only 25% of heterozygous or wild-type littermates developed severe stage 3 tonic-clonic seizures frequently associated with death (P Ͻ 0.004, Mann-Wilcoxon rank sum test). The severity of seizure, in the range from 0 to 3, was shifted toward increased severity in GIRK2 Ϫ͞Ϫ mice as compared with ϩ͞Ϫ and ϩ͞ϩ controls. No statistically significant difference was seen between heterozygous and wild-type mice (Fig. 4A) . The time taken to develop seizure activities was significantly shorter in GIRK2 Ϫ͞Ϫ mice compared with ϩ͞Ϫ and ϩ͞ϩ animals (P Ͻ 0.002, unpaired t-test; Fig. 4B ). Seizure activity has previously been noted in weaver mice and might be due to altered or reduced G protein-activated K ϩ channel function (14) . Our observation that GIRK1͞GIRK2-deficient mice are susceptible to spontaneous and pharmacologically induced seizures was consistent with numerous studies demonstrating that agonists of G protein-coupled receptors, such as receptors for opioid peptides, somatostatin, and dopamine, can have significant effects on seizure thresholds in several different experimental seizure model systems (30) .
In conclusion, we show that GIRK2-deficient mice have greatly reduced GIRK1 protein levels in the brain, suggesting that the majority of GIRK1 proteins in the brain associate with GIRK2. Phenotypic characteristics of GIRK2 Ϫ͞Ϫ, wv͞Ϫ, wv͞ϩ, and wv͞wv mice suggest that gain-of-function and gene dosage mechanisms are responsible for the developmental defects in weaver mutants. Moreover, loss of GIRK2 function results in sporadic seizures and increased susceptibility to a convulsant agent, implicating GIRK1 and GIRK2 in the control of neural excitability in vivo.
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FIG. 3. (A)
Coronal sections of brain from GIRK2 ϩ͞ϩ and Ϫ͞Ϫ mouse brains stained with antibodies against the N terminus of GIRK2, the N terminus of GIRK1, and the C terminus of IRK1 show that there is no detectable GIRK2 and dramatically reduced GIRK1 immunoreactivity in the GIRK2 Ϫ͞Ϫ mice. The IRK1 staining patterns are the same for these mice. CTX, cerebral cortex; HP, hippocampus; Th, thalamus. (Bar ϭ 10 mm.) (B) Sagittal views of cerebella from GIRK2 ϩ͞ϩ and Ϫ͞Ϫ mice stained with the antibodies described in A. Although there is no detectable GIRK2 protein in the Ϫ͞Ϫ mice, there is still significant GIRK1 staining, whereas the level of IRK1 expression appears to be the same. g, granule cell layer; m, molecular layer. (Bar ϭ 20 mm.) (C) Coronal sections of ventral midbrain from ϩ͞ϩ, Ϫ͞Ϫ, wv͞Ϫ, and wv͞wv mice are stained with antibodies against TH and the N terminus of GIRK2. The TH staining of ϩ͞ϩ, Ϫ͞Ϫ, and wv͞Ϫ midbrain appears similar, whereas there are fewer TH-positive neurons in the substantia nigra pars compacta (SNc) of the wv͞wv midbrain. GIRK2 immunoreactivity is absent in the Ϫ͞Ϫ midbrain but can still be found in the wv͞Ϫ and wv͞wv mice, although the dendritic staining is dramatically reduced. SNr, substantia nigra pars reticulata; (0, no response; 1, isolated twitches; 2, tonic-clonic convulsions; 3, tonic extension and͞or death). GIRK2 Ϫ͞Ϫ mice (n ϭ 16) tend to progress to more severe stages than ϩ͞ϩ or ϩ͞Ϫ mice (n ϭ 13 and 12, respectively; P Ͻ 0.004, Mann-Whitney U-Wilcoxon rank sum test). No statistically significant difference was observed between ϩ͞ϩ and ϩ͞Ϫ animals. (B) Seizure latency. The PTZ seizure latency was defined as the time elapsed from PTZ injection to the first obvious sign of tonic-clonic convulsion or tonic extension. The latency to seizures was shorter for the Ϫ͞Ϫ mice ‫,ء(‬ P Ͻ 0.002, unpaired test).
VTA, ventral tegmental area. (Bar ϭ 1 mm.) (D) High magnification views of parasagittal cerebellar sections from ϩ͞ϩ, Ϫ͞Ϫ, wv͞Ϫ, and wv͞wv mice. The sections are counterstained with toluidine blue or stained with antibody against the C terminus of IRK1, which stains the cell body and dendrites of the Purkinje cells as well as the dendrites in the granule cell layer. The wv͞Ϫ cerebellum is mostly wild-type in appearance except for regions with a Purkinje cell layer more disorganized and broader than that in GIRK2 ϩ͞ϩ and Ϫ͞Ϫ mice. Some Purkinje cells and their dendrites can be found in the granule cell layer of wv͞Ϫ mice. In the wv͞wv cerebellum, there is no granule cell layer, and the Purkinje cells with disorganized dendrites are scattered throughout the cerebellum. m, molecular layer; p, Purkinje cell layer; g, granule cell layer; p͞g, cell layer where both Purkinje cells and granule cells are found; m͞p, cell layer where molecular layer and Purkinje cell layers collapse into one in the absence of granule cell layer; wm, white matter. (Bar ϭ 0.2 mm.)
